JAZZ (Jazz Pharmaceuticals, Inc.) Stock Analysis - Politician Trades
Jazz Pharmaceuticals, Inc. (JAZZ) is a publicly traded Healthcare sector company. As of May 21, 2026, JAZZ trades at $242.70 with a market cap of $14.40B and a P/E ratio of 26.45. JAZZ moved +0.70% today. Year to date, JAZZ is +37.05%; over the trailing twelve months it is +115.29%. Its 52-week range spans $95.49 to $242.18. Analyst consensus is strong buy with an average price target of $241.43. Rallies surfaces JAZZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded JAZZ stock?
Rallies tracks politician and congressional stock disclosures for JAZZ, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Rallies tracks politician and congressional stock disclosures for JAZZ, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in JAZZ?
Yes. Rallies tracks politician and congressional stock disclosures for JAZZ, including reported purchases, sales, dates, owners, and trade amounts when available.
Is JAZZ research on Rallies investment advice?
No. Rallies provides research, data, and educational context for JAZZ. It does not provide personalized investment advice.
